Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Public ClinicalTrials.gov record NCT06088381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm Phase II Trial Evaluating Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Study identification
- NCT ID
- NCT06088381
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Experimental Observation Other
- Observation per Standard of Care Other
- Adjuvant Treatment per Standard of Care Radiation
- Circulating Tumor DNA test (ctDNA test) Diagnostic Test
Other · Radiation · Diagnostic Test
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 6, 2024
- Primary completion
- Dec 17, 2028
- Completion
- Dec 17, 2030
- Last update posted
- Nov 9, 2025
2024 – 2030
United States locations
- U.S. sites
- 5
- U.S. states
- 1
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Maryland Proton Treatment Center | Baltimore | Maryland | 21201 | Recruiting |
| University of Maryland Greenebaum Cancer Center | Baltimore | Maryland | 21201 | Recruiting |
| Upper Chesapeake Health | Bel Air | Maryland | 21014 | Not yet recruiting |
| Central Maryland Radiation Oncology | Columbia | Maryland | 21044 | Not yet recruiting |
| Baltimore Washington Medical Center | Glen Burnie | Maryland | 21061 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06088381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06088381 live on ClinicalTrials.gov.